The U.S. House committee is raising concerns over GenScript's ties to China. Discover the latest developments in ...

Trinity Biotech reported a 3% increase in Q3 2024 revenue to $15.2 million, driven by strong demand for its TrinScreen HIV business. The company also highlighted significant growth in its Point-of ...

Trinity Biotech acquired EpiCapture for initial consideration of approximately $3M, with an additional consideration of $0.5M contingent on the achievement of future milestones.

Trinity Biotech acquired EpiCapture for initial consideration of approximately $3 million, with an additional consideration of $0.5 million contingent on the achievement of future milestones.

DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), a company specializing in human diagnostics and diabetes management, has acquired EpiCapture Limited, a firm developing a non-invasive test for ...

DUBLIN, Ireland, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, ...

Trinity Biotech intends to use this breakthrough process to stabilise and improve the functionality of the glucose biosensor in its next generation continuous glucose monitor (CGM) technology.

As Trinity Biotech plc (NASDAQ:TRIB) welcomes Adrian Donohue as its new Chief Commercial Officer, the company's financial health and market performance are critical to its strategic transformation.

Commenting on the appointment, John Gillard, CEO of Trinity Biotech plc, said “We are delighted to welcome Louise, who brings extensive experience in transformation and growth within a dynamic ...

Trinity Biotech sells direct in the United States, Germany, France, and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide.